Application 208383

Type
NDA
Sponsor
PORTOLA PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BEVYXXABETRIXABANCAPSULE;ORAL40MGYesNo
002BEVYXXABETRIXABANCAPSULE;ORAL80MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69853-0201BEVYXXAbetrixabanPortola Pharmaceuticals, Inc.NDACurrent
69853-0201BEVYXXAbetrixabanPortola Pharmaceuticals, NDACurrent
69853-0201BEVYXXAbetrixabanPortola Pharmaceuticals, Inc.NDACurrent
69853-0202BEVYXXAbetrixabanPortola Pharmaceuticals, Inc.NDACurrent
69853-0202BEVYXXAbetrixabanPortola Pharmaceuticals, NDACurrent
69853-0202BEVYXXAbetrixabanPortola Pharmaceuticals, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
64466SUPPL2020-09-01
64412SUPPL2020-08-25
59386SUPPL2019-07-19
59380SUPPL2019-07-19
49056ORIG2017-07-25
49000SUPPL2017-07-17
48997SUPPL2017-07-17
48813ORIG2017-06-23
48812ORIG2017-06-23
48811ORIG2017-06-23